Comparative neuropathology of kuru with the new variant of Creutzfeldt- Jakob disease: Evidence for strain of agent predominating over genotype of host

Brain Pathology

Volumn 8, Issue 3, 1998, Pages 429-437

  McLean, C A ^a   Ironside, J W ^b   Alpers, M P ^c   Brown, P W ^d   Cervenakova, L ^d   Andersor, R Mc D ^a   Masters, C L ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

^c PAPUA NEW GUINEA INSTITUTE OF MEDICAL RESEARCH   (Papua New Guinea)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN;

ARTICLE; BRAIN SPONGIOSIS; CLINICAL ARTICLE; CLINICAL FEATURE; CREUTZFELDT JAKOB DISEASE; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KURU; NEUROPATHOLOGY; PROTEIN LOCALIZATION; STRAIN DIFFERENCE; SYNDROME DELINEATION;

EID: 0031804370     PISSN: 10156305     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1750-3639.1998.tb00165.x     Document Type: Article

References (37)

1. Alpers M (1968) Kuru: Implications of its transmissibility for the interpretation of its changing epidemiological pattern. In: Bailey OT, Smith DE (eds.), pp. 234-251. The Central Nervous System, Some Experimental Models of Neurological Diseases, International Academy of Pathology Monograph No 9. Williams and Wilkins: Baltimore, London, Sydney
2. Beck E and Daniel P (1979) Kuru and CreutzfeJdt-Jakob disease; Neuropathological lesions and their significance. In: Slow Transmissible Diseases of the Nervous System, Prusiner SB, Hadlow WJ (eds.), pp. 253-270, Academic Press: New York, London, Sydney, Toronto, San Francisco
3. Bell JE Neuropathological diagnosis of human prion disease. In: Methods in Molecular Medicine - Prion Diseases, Baker HR Ridley RM (eds.), Chapter 4, pp. 59-83, Humana Press: Totowa
4. Bell JE, Gentleman SM, Ironside JW, McCardle L, Lantos PL, Doey L, Lowe J, Fergusson J, Luthert P, McQuaid S, Alien IV (1997) Prion protein immunocytochemistry - UK five centre consensus report. Neuropathol and Appl Neurobiol 23: 26-35
5. Billette de Villemeur TB, Destys JP, Pradel A, Soubne C, Alperovitch A, Tardieu M, Chaussain JL, Hauw JJ, Dormont D, Ruberg M and Agid Y (1996) Creutzfeldt-Jakob disease from contaminated growth hormone extracts in France. Neurology 47: 690-695
6. Bruce ME Strain typing studies of scrapie and BSE. In: Methods in Molecular Medicine - Prion Diseases, Baker HF, Ridley RM (eds.), Chapter 13, pp. 223-235, Humana Press: Totowa
7. Bruce ME, Will RG, Ironside JW, McConnell, Drummond D, Suttle A, McCardle L, Chree A, Hope J, Birkett C, Cousens S, Fraser H, Bostock CJ (1997) Transmission to mice indicates that 'new variant' CJD is caused by the BSE agent. Nature 389: 498-501
8. Budka H, Aguzzi A, Brown P, Brucher J-P, Gugiani O, Gullotta F, Haltia M, Hauw J-J, Ironside JW, Jellinger K, Kretzschmar HA, Lantos PL, Masullo C, Schlote WS, Tateishi J and Welter R (1995) Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol 5: 459-466
9. Chesebro B. BSE AND Prions: Uncertainties about the agent (1998) Science 279:42-43
10. Coliinge J, Sidle KC, Meads J, Ironside J and Hill AF (1996) Molecular analysis of pnon strain variation and the aetiology of 'new variant' CJD. Nature 383: 685-690
11. Cousens SN, Vynnycky E, Zeidler M, Will RG Smith PG (1997) Predicting the CJD epidemic in humans. Nature 385:197-198
12. de Suva R, Ironside JW, McCardle L, Esmond T, Bell J, Will R, Windl O, Dempster M, Estibeiro P and Lathe R (1994) Neuropathological phenotype and 'prion protein' genotype correlation in sporadic Creutzfeldt-Jakob disease. Neurosci Let 179: 50-52
13. DeArmond SJ and Prusiner SB Prion diseases. In: Greenfield's Neuropathology, Graham Dl, Lantos PL (eds.), Chapter 5, pp. 235-280, Edward Arnold: London, Sydney, Auckland
14. Deslys J-P, Marce D and Dormont D (1994) Similar genetic susceptibility m latrogenic and sporadic CreutzfeldtJakob disease. J Gen Virol 75: 23-27
15. Fowler M and Robertson EG (1958) Observations on kuru. III: Pathological features in five cases. Australasian Ann Med 8:16-26
16. Hainfellner JA, Liberski PP, Guiroy DC, Cervenakova L, Brown P, Gajdusek DC and Budka H (1997) Pathology and immuncytochemistry of a kuru brain. Brain Pathot 7: 547-553
17. Hainfellnner JA, Brantner-lnthaler S, Cercenakova L, Brown P, Kitamoto T, Tateishi J, Diringer H, Libersi PP, Regele H, Feucht M, Mayr N, Wessley P, Summer K, Seitelberger F and Budka H (1995) The original GerstmannStraussler-Scheimker family of Austria: divergent clinicopathological phenotypes but constant PrP genotype. Brain Pathol 5: 201-213
18. Hayward PAR, Bell JE and Ironside JW (1994) Prion protein immunochemistry: The development of reliable protocols for the investigation of Creutzfeldt-Jakob disease. Neuropathol Appl NeurobioI 20: 375-383
19. Hill AF, Desbruslais M, Joiner S, Sidle KCL, Gowland I, Collinge, Doey LJ, Lantos P. The same pnon strain causes vCJD and BSE (1997) Nature 389:448-450
20. Ironside JW New variant Creutzfeldt-Jakob disease in the UK - Clinical and pathological studies (1997) Brain Pathol 7:1243-1245
21. Ironside JW (1996) Review: Creutzfeldt-Jakob disease. Brain Pathol 6:379-388
22. Kitamoto T, Shin RW, Doh-ure K, Tomokane N, Miyazono M, Muramoto T, Tatesi J (1992). Abnormal isoform of prion protein accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt- Jakob disease. Am J Pathol 140: 1285-1294
23. Kakulas BA, Lecours AR and Gajdusek DC (1967) Further observations on the pathology of kuru. J Neuropathol Exp Neurol 26:85-97
24. Klatzo I, Gajdusek DC and Zigas V (1959) Pathology of kuru. Lab Invest 8:799-847
25. Lantos P, Bhatia K, Doey LJ, Al-Sarraj S, Doshi R, Beck J and Collinge J (1997) Is the neuropathology of new variant Creulzfeldt-Jakob disease and kuru similar?. Lancet 350: 187-188
26. MacDonald ST, Sutherland K and Ironside JW (1996) Pnon protein genotype and patholgical phenotype studies in sporadic Creutzfeldt-Jakob disease. Neuropathol Appl Neurobiol 22: 285-292
27. Masters CL, Gajdusek DC, Gibbs CJ (1981) CreutzfeldtJakob disease virus isolations from the GerstmannSträussler Syndrome with an analysis of the various forms of amyloid plaque deposition in the virus-induced spongiform encephalopathies Brain 104:594-588
28. Masters CL, Richardson EP, Jr (1978) Subacute spongiform encephalopathy (Creutzfeldt-Jakob disease) The nature and progression of spongiform changes. Brain 101:333-334.
29. Neumann MA, Gajdusek DC and Zigas V (1964) Neuropathological findings in exotic neurologic disorders among natives of the highlands of New Guinea. J Neuropath Exp Neurol 23:486-507
30. Parchi P, Capellari S, Chen SG, Petersen RB, Gambetti P, Kopp N, Brown P, Kitamoto T, Tateishi J, Giese A, Kretzschmar H (1997) Typing prion isoforms. Nature 386:232-233.
31. Parchi P. Castellani R, Capellari S, Ghetti B, Young K, Chen SG, Farlow M, Dickson DW, Sima AAF, Trojanowski JQ, Petersen RB and Gambetti P (1996) Molecular basis of phenotypic variability in sporadic CreutzfeldtJakob disease. Ann Neurol 39: 767-778
32. cjo in the nervous system. Brain Pathol 5: 33-41
33. Schulz-Schaffer WJ, Giese A, Windl O and Kretzschmar HA (1996) Polymorphism at codon 129 of the prion protein gene determines cerebellar pathology in CreutzfeldtJakob disease. Clin Neuropathol 15: 353-357
34. Shimizu H, Burns JC. PCR Strategies.(1995) Academic Press, Inc. Innis MA, Gelfand DH, Sninsky JJ(eds) pp32-38.
35. Weller RO, Steart PV and Powell-Jackson JD (1986) Pathology of Creutzfeldt-Jakob disease associated with pituitary-derived human growth hormone administration. Neuropathol Appl Neurobiol 12: 117-129
36. Wells GAH and Wilesmith JW (1995) The neuropathology and epidemiology of bovine spongiform encephalopathy. Brain Pathol 5:91 -103
37. Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, Poser S, Pocchiari M, Hofman A (1996) A new variant of Creutzfeldt-Jakob disease in the UK. Lancer 347: 921-25